Skip to Main Content

Paper Details

Enhancing evaluation of sarcopenia in patients with non-small cell lung cancer (NSCLC) by assessing skeletal muscle index (SMI) at the first lumbar (L1) level on routine chest computed tomography (CT).
Support Care Cancer
35
2018
  • 1 - 1

Datasets